Company Search:
Advanced Search
Sponsored Links
Zymeworks Inc Company Snapshot
Zymeworks Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zymeworks Inc with three other companies in this sector in the United States: Pharmaxis Ltd (2016 sales of $13.50 million of which 80% was Bronchitol and Aridol), Dimension Therapeutics Inc ($11.47 million of which 100% was Pharmaceutical), and Immune Design Corp ($13.26 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zymeworks Inc
  Stock Performance Chart for Zymeworks Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 10.28
(Figures in U.S. Dollars)
1 Week 8.3%   13 Weeks 37.0%  
4 Weeks 14.2%   52 Weeks n/a  
Zymeworks Inc Key Data:
  Ticker: ZYME Country: Canada
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 11,009,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 260,383,242
  Fiscal Yr Ends: December Shares Outstanding: 25,339,955
  Share Type: Common Closely Held Shares: 11,693,418
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.